Association of colorectal adenoma with other malignancies in Swedish families by Hiripi, E et al.
Association of colorectal adenoma with other malignancies
in Swedish families
E Hiripi*,1, J Lorenzo Bermejo
1, J Sundquist
2 and K Hemminki
1,2
1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Germany;
2Karolinska
Institute, Center for Family and Community Medicine, Huddinge 141 83, Sweden
Using the Swedish Family-Cancer Database covering over 11.5 million individuals, estimated relative risks (RRs) for colorectal
adenoma were using Poisson’s regression. The RR of colorectal adenoma was found to be increased among first-degree relatives of
patients with colorectal cancer (2.72; 95% confidence interval¼2.46–3.00) and among the offspring and siblings of patients with
endometrial and prostate cancers. We also found an increased risk of colorectal adenoma for the offspring of individuals with
stomach cancer and leukaemia, and for siblings of those with pancreatic cancer and multiple myeloma. Our results suggest that
colorectal adenoma may share a genetic aetiology with cancer even at extracolorectal sites. Increases of colorectal adenoma in
families affected by prostate cancer and acute leukaemia cannot be attributed to known cancer syndromes, although the play of
chance cannot be excluded.
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Most colorectal cancers (CRCs) develop through sequential
malignant transformations of adenomatous polyps (Bond, 2000).
Mutations in the adenomatous polyposis coli gene are responsible
for the early stage of adenoma formation in familial adenomatous
polyposis (Houlston, 2001; Lynch and de la Chapelle, 2003;
Molatore and Ranzani, 2004) and mutations in the mismatch-
repair genes are associated with hereditary nonpolyposis CRC
(HNPCC) (Lynch and de la Chapelle, 2003; Molatore and Ranzani,
2004). The later stages of adenoma development into CRCs include
K-ras, p53 and mismatch-repair genes (Lynch and de la Chapelle,
2003; Molatore and Ranzani, 2004).
The adenoma–carcinoma sequence implies that colorectal
adenomas and carcinomas have common risk factors. A family
history of CRC increases the risk of CRC (Slattery and Kerber,
1994; Hemminki and Li, 2001; Andrieu et al, 2004; Stefansson et al,
2006) and is a strong risk factor for adenoma growth (Lindgren
et al, 2002; Almendingen et al, 2003). Although an association
between CRC risk and a family history of extra-colorectal
malignancies has been reported previously (Slattery and Kerber,
1994; Hemminki and Li, 2001; Andrieu et al, 2004), little is known
on the corresponding risk of colorectal adenoma.
We have therefore quantified the risk of colorectal adenoma
among individuals with a family history of any cancer using the
nationwide Swedish Family-Cancer Database with its unique
capacity for accurate and unbiased assessment (Hemminki and
Li, 2001; Hemminki et al, 2001b).
MATERIALS AND METHODS
The population-based Swedish Family-Cancer Database was
created by linking the Multigeneration Register at Statistics
Sweden to the Swedish Cancer Registry (Hemminki et al, 2001b).
This is based on compulsory reports from pathologists and
cytologists, on every cancer diagnosis on surgically removed
tissues, biopsies, cytological specimens, bone marrow aspirates
and autopsies (Center for Epidemiology, 2004). The Multigenera-
tion Register includes individuals born in Sweden after 1931 and
their biological parents and its latest update covers over 11.5
million individuals. Cancer/adenoma data were retrieved from the
Swedish Cancer Registry from 1961 to 2004. Database coverage is
practically complete but some familial links are missing from
offspring born before 1941 and dying in 1960–1997 reducing the
number of fatal cancers among offspring. This is unlikely to bias
familial studies because familial and sporadic cases would be
reduced proportionately (Hemminki et al, 1998; Hemminki and
Vaittinen, 1999). The present study relies on individuals with
information about both parents. Family history was restricted to
first-degree relatives, parents, and siblings.
From International Classification of Diseases (ICD-7) the
following codes were used: for colorectal adenomas 094; CRCs
by anatomic site: 1530 (ascending), 1531 (transverse), 1532
(descending), 1533 (sigmoid), 1538 (multiple sites), 1534 and
1539 (other sites), 154 – excluding 1541 (rectum). Follow-up
started from the date of birth, immigration or 1 January 1961,
whichever occurred last. Follow-up ended on the date of diagnosis
of CRC or colorectal adenoma, death, emigration, or the closing
date of the study (31 December 2004), whichever came first.
Relative risks (RRs) with 95% confidence intervals (CIs) were used
to compare adenoma incidence among those whose family was
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population. Cases of adenoma and person – years were classified
according to gender, family history of cancer, calendar year and
age. The distribution of the number of cases in each group was
modelled by Poisson’s regression. The Genmod procedure of the
SAS software was used for the analysis (SAS Version 9.1; SAS
Institute, Cary, NC, USA).
RESULTS
The Database included 2943 individuals diagnosed with colorectal
adenoma and with information about both parents. The parental
generation incorporated 12458 individuals with colorectal adeno-
ma. The incidence of colorectal adenoma in Sweden has been
increasing since the 1960s; the site-specific age-adjusted incidence
rates for 1990–1999 and 2000–2004 are displayed in Table 1.
Table 2 shows some demographic characteristics and RRs. Women
were at a slightly lower risk of colorectal adenoma compared to
men (RR¼0.89; 95% CI¼0.82–0.94). As expected, age was
associated with risk, which was also increased with a family
history of CRC (RR¼2.72; 95% CI¼2.46–3.00) and particularly of
colorectal adenoma (RR¼4.99; 95% CI¼4.12–6.05). Among the
108 patients with colorectal adenoma and also a family history of
this, 55 individuals (in 27 families) had an affected sibling
(RR¼9.41; 95% CI¼7.21–12.3).
Standard Poisson’s regression assumes independent observa-
tions. Because of possible overdispersion due to clustered family
structure, s.e. were adjusted using Pearson’s w
2, divided by the
degrees of freedom, resulting in slightly wider CIs. For example,
the RR of colorectal adenoma for individuals with a positive family
history was 4.99 (95% CI¼3.36–7.41). However, as this procedure
may be sensitive to outlying observations to be expected in our
large data set, we show unadjusted CIs and point out the possibly
conservative limits due to familial dependence.
The left column of Table 3 shows colorectal adenoma RRs
according to parental history of CRC and colorectal adenoma: it
was increased among offspring of patients with colon cancer
(RR¼2.59; 95% CI¼2.28–2.94), rectal cancer (RR¼2.59; 95%
CI¼2.20–3.05), colon adenoma (RR¼4.43; 95% CI¼3.09–6.34),
and rectal adenoma (RR¼2.62; 95% CI¼1.77–3.89). Correspond-
ing risks with a sibling history of CRC and colorectal adenoma are
displayed in the right column of Table 3, with particularly high
risks when a sibling had colon (RR¼11.3; 95% CI¼8.15–15.7) or
rectal adenoma (RR¼6.94; 95% CI¼4.42–10.9). Colorectal
adenoma was higher for the offspring of individuals with colon
adenoma (RR¼4.43) than those with colon cancer (RR¼2.59;
P-value o0.01). It was also higher for those with a sibling with
colon adenoma (RR¼11.3) than when a sibling had colon cancer
(RR¼2.64; P-value o0.01). Colorectal adenoma risk was higher
when a sibling had rectal adenoma (RR¼6.94), than when a
sibling had rectal cancer (RR¼2.75; P-value o0.01).
The offspring risk of colorectal adenoma was higher when
parents had multiple adenomas than when parents presented with
single adenomas (RR¼21.6; 95% CI¼5.70–82.0). Sibling risk was
also significantly higher for multiple than for single adenomas in
any colorectal site (RR¼20.7; 95% CI¼3.48–123) (results not
shown).
Table 4 shows colorectal adenoma RRs with a family history of
malignancies other than CRC, but only for sites where at least 10
individuals with a family history of cancer had colorectal adenoma.
The risk was increased among the offspring of parents with
leukaemia (RR¼1.34; 95% CI¼1.02–1.76). Among the 53 affected
parents, 17 had chronic lymphoblastic, 14 acute myeloid, 5 acute
lymphoblastic (ALL), 2 chronic myeloid leukaemias; 7 type
unspecified; 8 polycythaemia vera. Colorectal adenoma risk was
the highest among the offspring of the five patients with ALL
(RR¼3.38; 95% CI¼1.41–8.14) in which the leukaemias were
diagnosed at advanced ages (63–94 years). Risk was also increased
among the offspring of parents with acute myeloid leukaemia
(RR¼1.79; 95% CI¼1.06–3.02). It was also increased among
individuals with a parental history of stomach (RR¼1.28; 95%
Table 1 Age standardised incidence of colorectal adenoma/100000
person-years diagnosed in Sweden between 1990 and 2004 (adjusted to
world standard population 2000)
Site 1990–1999 2000–2004
Colorectum 3.29 5.03
Colon 1.65 2.89
Ascending 0.24 0.52
Transverse 0.15 0.31
Descending 0.07 0.16
Sigmoid 0.81 1.34
Other 0.36 0.52
Multiple 0.02 0.04
Rectum 1.64 2.14
Table 2 Relative risk of colorectal adenoma according to sex, age,
calendar year, and family history of colorectal cancer/adenoma
Covariate Level N RR (95% CI)
Gender Females 1365 0.89 (0.82–0.94)
Males 1578 1.00 (ref.)
Age of diagnosis Before 50 706 0.03 (0.02–0.04)
50–54 449 0.26 (0.21–0.33)
55–59 628 0.49 (0.40–0.59)
60 and above 1160 1.00 (ref)
Calendar year of diagnosis Before 1980 90 0.18 (0.11–0.28)
1980–1989 282 0.58 (0.43–0.78)
1990–1999 1038 0.67 (0.57–0.79)
2000–2004 1533 1.00 (ref.)
Family history of colorectal cancer Yes 474 2.72 (2.46–3.00)
No 2469 1.00 (ref.)
Family history of colorectal adenoma Yes 108 4.99 (4.12–6.05)
No 2835 1.00 (ref.)
Bold signifies Po0.05.
Table 3 Relative risk of colorectal adenoma for the offspring/sibling of
individuals with colorectal cancer/adenoma
Colorectal adenoma
Offspring Sibling
NN
Location in parent/sibling RR (95% CI) RR (95% CI)
Invasive cancer
Colon 264 50
2.59 (2.28–2.94) 2.64 (2.00–3.50)
Rectum 153 33
2.59 (2.20–3.05) 2.75 (1.95–3.88)
Adenoma
Colon 30 36
4.43 (3.09–6.34) 11.3 (8.15–15.7)
Rectum 25 19
2.62 (1.77–3.89) 6.94 (4.42–10.9)
Bold signifies Po0.05.
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prostate (RR¼1.17; 95% CI¼1.03–1.34) cancers. Colorectal
adenoma showed increases among those whose siblings had
multiple myeloma (RR¼2.63; 95% CI¼1.42–4.90), endometrial
(RR¼1.63; 95% CI¼1.05–2.54) and pancreatic cancer (RR¼2.18;
95% CI¼1.27–3.77). The risk was also increased when parents or
siblings had cancer at any site (RR¼1.50; 95% CI¼1.39–1.61,
RR¼1.44; 95% CI¼1.30–1.59, respectively).
The risk of site-specific colorectal adenoma was examined
according to parental and sibling history of cancer at specific sites
(result not shown). Sigmoid adenomas were associated with
parental history of liver cancer (RR¼1.69; 95% CI¼1.09–2.64;
N¼20), and with a sibling history of melanoma (RR¼2.06; 95%
CI¼1.13–3.73; N¼11). A sibling history of cervical or nervous
system cancer was associated with an increased risk of rectal
adenoma (RR¼2.44; 95% CI¼1.31–4.54; N¼10, RR¼1.72;
95% CI¼1.02–2.92; N¼14, respectively). Rectal adenoma was
also related to parental history of melanoma (RR¼1.63;
95% CI¼1.06–2.51 N¼21).
DISCUSSION
The present study indicates that individuals with first-degree
relatives with colorectal adenoma have an approximately five times
higher probability of this neoplasm than those without a family
history; the risk being particularly high among relatives of those
with multiple adenomas. As in previous studies risk was increased
among offspring and siblings of CRC patients (Bonelli et al, 1988;
Tung and Wu, 2000; Lindgren et al, 2002).
To our knowledge, there are no studies of colorectal adenoma in
relation to a family history of extracolonic cancers. The present
data suggest an involvement of colorectal adenoma in HNPCC and
associations with the commonest HNPCC cancer sites – endome-
trium, stomach, pancreas and nervous system – were identified
(Lynch and de la Chapelle, 2003).
We also found colorectal adenoma associated with some extra-
colorectal cancers unrelated to CRC. There was a higher risk of
colorectal adenoma for the offspring and siblings of patients with
prostate cancer. The siblings of patients with multiple myeloma and
the offspring of patients with leukaemia were at an increased risk of
colorectal adenoma. Increased risks of CRC are reported among first-
degree relatives of patients with leukaemia (Andrieu et al, 2004;
Hemminki and Chen, 2004), myeloma (Hemminki and Li, 2001), and
prostate cancer (Slattery and Kerber, 1994). We also found that the
offspring of those with adult acute lymphoblastic leukaemia were at a
higher risk of colorectal adenoma. Rectal adenoma risk was increased
among siblings of women with cervical cancer. An increased risk of
rectal cancer before the age of 50 years has been reported among the
offspring of women with cervical cancer after the age of 50 years
(Hemminki and Chen, 2004), but the risk was not increased among
siblings of such women. Moreover, the risk of rectal cancer as a
second tumour seems to be increased after a first cervical cancer
(Hemminki et al,2 0 0 1 a ) .T h ef a m i l i a la s s o c i a t i o no fr e c t a la d e n o m a
with melanoma should be investigated using independent data.
Our study had the advantage of information on the anatomical
location of the colonic tumours, but our analyses were limited by
small numbers, although this problem can be addressed when the
Database in further updated. During our study, Sweden had no
population-based screening programmes for CRC (Hakama et al,
2005). Some individuals in our study may have undergone
colonoscopic screening because of a family history of CRC, as
the risks reported in Tables 2 and 3 could be overestimated.
Another limitation is that only precancerous lesions and gastro-
intestinal polyps with suspected malignancy are compulsorily
reported to the Cancer Registry and some adenomas might be
already precancerous. A shortcoming is the lack of data on tobacco
smoking, alcohol consumption, or diet.
Table 4 Relative risk of colorectal adenoma for the offspring/siblings of
individuals with invasive cancer
Colorectal adenoma
Offspring Sibling
NN
Cancer site in parent/sibling RR (95% CI) RR (95% CI)
Tongue/mouth 27 5
1.12 (0.76–1.63) 0.79 (0.33–1.89)
Stomach 100 9
1.28 (1.05–1.57) 1.35 (0.70–2.59)
Liver 56 6
1.22 (0.93–1.58) 1.12 (0.50–2.49)
Pancreas 51 13
1.12 (0.85–1.48) 2.18 (1.27–3.77)
Lung 108 31
1.13 (0.93–1.37) 1.35 (0.95–1.92)
Breast 151 80
1.04 (0.88–1.22) 1.05 (0.84–1.31)
Cervix uteri 22 13
0.81 (0.53–1.23) 1.46 (0.85–2.51)
Endometrium 51 20
1.45 (1.10–1.91) 1.63 (1.05–2.54)
Ovary 28 11
0.88 (0.60–1.27) 0.93 (0.52–1.69)
Prostate 233 59
1.17 (1.03–1.34) 1.45 (1.12–1.88)
Kidney 55 4
1.22 (0.93–1.59) 3.25 (1.22–8.68)
Urinary organs 72 12
1.10 (0.87–1.39) 0.87 (0.49–1.53)
Melanoma 36 28
1.30 (0.94–1.81) 1.34 (0.93–1.95)
Squamous cell skin 51 13
0.94 (0.71–1.24) 1.67 (0.97–2.87)
Nervous system 37 21
1.06 (0.77–1.47) 1.19 (0.77–1.83)
Endocrine glands 18 13
0.88 (0.55–1.40) 1.36 (0.79–2.34)
Connective tissue 10
1.16 (0.62–2.15)
Non-Hodgkin lymphoma 39 3
1.04 (0.76–1.43) 1.26 (0.41–3.91)
Multiple myeloma 21 10
0.93 (0.61–1.44) 2.63 (1.42–4.90)
Leukaemia 53 9
1.34 (1.02–1.76) 0.95 (0.49–1.83)
Any cancer 1446 451
1.50 (1.39–1.61) 1.44 (1.30–1.59)
Bold signifies Po0.05.
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risk factor for colorectal adenoma particularly for first-degree
relatives of patients with multiple adenomas. Unrelated to
known CRC syndromes, we found increases among the
offspring and siblings of patients with prostate cancer, and the
offspring of patients with leukaemia. However, given the number
of tests performed, chance may have operated in some of
our findings. Our data may help to understand the
adenoma–carcinoma sequence and to develop prevention
strategies.
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